Policy Levers (500 Cohort)
10-Yr Horizon
Venture Funnel & Terminal Outcomes
Cohort n=500
Unicorns ($1B+)
3
0.6% yield
Micro-IPOs (<$100M)
74
TSE Growth Exits
Series B/C Stalls
188
Growth Valley of Death
Total Value Created
$14.2B
Med Exit: $48.5M
Dissolved / Failed
Micro-IPO Exits
Growth Stalls (Zombies)
Strategic M&A
Unicorn ($1B+)
β οΈ Structural Diagnostic: Premature Liquidity Trap
High TSE Growth listing pressure siphons 74 potential scaleups into sub-$100M public companies. While providing quick founder/angel liquidity, public quarterly compliance and risk-averse retail shareholders halt aggressive R&D compounding before reaching unicorn scale.
Global Venture Benchmarks
Per 500 Seed Cohort
| Ecosystem | Unicorns | Micro-IPO | M&A | Cohort EV |
|---|---|---|---|---|
| π―π΅ Current Sim | 3 (0.6%) | 74 | 46 | $14.2B |
| πΊπΈ Silicon Valley | 18 (3.6%) | 6 | 112 | $78.4B |
| π¬π§ UK / Europe | 9 (1.8%) | 18 | 84 | $36.1B |
| π°π· South Korea | 6 (1.2%) | 42 | 58 | $24.5B |
| π―π΅ Japan Hist. (2015-24) | 2 (0.4%) | 82 | 38 | $11.8B |
The Economist Causal Breakdown
1. The "Small IPO" Safety Valve: Unlike the US where startups stay private 10β12 years, Japan's TSE Growth allows IPOs with only ~$10M revenue. Founders exit early rather than braving late-stage dilution.
2. CVC Minority Syndicates: Corporate VCs prioritize business partnerships over 100x financial returns, discouraging high-burn global expansion.
3. Golden Handcuffs: Japanese lifetime employment at giants (Toyota, Sony, Mitsubishi) starves startups of mid-career executive operators.
Cohort Terminal Distribution: